JENICE CHUMMAR
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology NEW HYDE PARK, NY NPI 1669898706
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology NY Ascendis Pharma Inc All categories
General Payments — all program years on this page
$2,572.34
- Category: General Payments
- Program years: PY2019–2024
- Record count: 101
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,298.93 across 47 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,298.93 | 47 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Ascendis Pharma Inc | $224.74 | 5 |
| SANOFI-AVENTIS U.S. LLC | $190.39 | 5 |
| Azurity Pharmaceuticals, Inc. | $178.32 | 8 |
| QOL Medical, LLC | $67.53 | 2 |
| BioMarin Pharmaceutical Inc. | $64.89 | 1 |
| Endo USA, Inc. | $54.99 | 3 |
| ABBVIE INC. | $52.20 | 2 |
| ACADIA Pharmaceuticals Inc | $52.12 | 2 |
| Abbott Laboratories | $40.27 | 2 |
| TOLMAR, INC. | $39.26 | 2 |
| UCB, Inc. | $34.22 | 1 |
| Insulet Corporation | $33.99 | 2 |
| Alexion Pharmaceuticals, Inc. | $29.91 | 1 |
| Amneal Pharmaceuticals LLC | $29.61 | 1 |
| Novo Nordisk AS | $29.42 | 1 |
| Corium, Inc. | $28.31 | 2 |
| Supernus Pharmaceuticals, Inc. | $26.84 | 1 |
| Cumberland Pharmaceuticals, Inc. | $23.25 | 1 |
| Tandem Diabetes Care, Inc. | $21.41 | 1 |
| Endo Pharmaceuticals Inc. | $20.21 | 1 |
| BAXTER HEALTHCARE | $20.11 | 1 |
| PFIZER INC. | $19.01 | 1 |
| Amphastar Pharmaceuticals, Inc. | $17.93 | 1 |
By program year
Records — PY2024 (47)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.